ABUS · Arbutus Biopharma Corp · Proposed Sales
Market Cap
$1.01B
Shares
197.85M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-04-21 | McElhaugh Michael J. | Director | 246,886 | 2025-04-21 | Rockefeller Capital Management |
| 2025-04-15 | McElhaugh Michael J. | Director | 53,114 | 2025-04-15 | Rockefeller Capital Management |
| 2025-03-31 | Sofia Michael J. | Officer | 250,000 | 2025-03-31 | Fidelity Brokerage Services LLC |
| 2025-03-24 | Sofia Michael J. | Officer | 250,000 | 2025-03-24 | Fidelity Brokerage Services LLC |
| 2025-03-19 | Sofia Michael J. | Officer | 150,000 | 2025-03-19 | Fidelity Brokerage Services LLC |
| 2025-03-13 | Sofia Michael J. | Officer | 100,000 | 2025-03-13 | Fidelity Brokerage Services LLC |
| 2025-03-07 | Sofia Michael J. | Member of immediate family of any of the foregoing | 167,162 | 2025-03-07 | Fidelity Brokerage Services LLC |
| 2025-02-04 | Michael J. McElhaugh | Director and Officer | 23,790 | 2025-02-04 | Morgan Stanley Wealth Management Canada |
| 2025-02-04 | Karen Sims | Officer | 19,348 | 2025-02-04 | Morgan Stanley Wealth Management Canada |
| 2025-02-04 | David C. Hastings | Officer | 22,183 | 2025-02-04 | Morgan Stanley Wealth Management Canada |
| 2025-02-04 | J. Christopher Naftzger | Officer | 11,333 | 2025-02-04 | Morgan Stanley Wealth Management Canada |
Showing 1–11 of 11 filings